Bresol a novel approach in allergic rhinitis : A clinical study

Allergic rhinitis is a very common disorder that affects people of all ages affects quality of life and productivity at work. Antihistamines, sympathomimetics, xanthine derivatives are commonly used as the treatment for symptomatic management, but they do not prevent recurrent episodes. . Bresol tablets is polyherbal formulations indicated for the management of allergic rhinitis. 100 subjects of either sex aged between 15 to 60 years and suffering from allergic rhinitis like sneezing, nasal congestion, itching of the eyes, itching of the nose, postnasal drip, rhinorrhoea and watery eyes were included in the study. Subjects were advised to consume two Bresol tablets, twice-daily for 6 weeks. All subjects were investigated for evaluated for symptomatic improvement of allergic rhinitis (sneezing, nasal congestion, itching of the eyes, itching of the nose, postnasal drip, rhinorrhea and watery eyes). Subjects were investigated by hematological and biochemical tests at the end of the study period. Bresol tablets significantly reduced the symptoms of allergic rhinitis namely sneezing, nasal congestion, itching of nose, postnasal drip and rhinorrhea and also significantly reduced elevated Total leukocyte count , Erythrocyte sedimentation rate and Absolute eosinophyl count levels without causing clinically significant adverse reactions. Thus it can be concluded that the Bresol tablets are effective and safe in the management of allergic rhinitis.